Companies similar to EXUMA BIOTECHNOLOGY
Sign up to Download

1-30 of 6,514,634 results

  • ingeneron.com
  • 2
  • 2
  • 11
InGeneron is a clinical-stage biotechnology company developing cell-based therapies to redefine the standard of care in orthopedics... At InGeneron we use the term "regenerative cell therapy" since there are many different cell types and..
Relevance: 46.893387
  • exumabio.com
  • 1
  • 4
  • 13
EXUMA Biotech is a clinical-stage biotechnology company discovering and developing cell and gene therapies for solid & liquid tumors... As part of our commitment to make cell therapies more accessible to earlier lines of therapy, we are developing..
Relevance: 46.028778
  • celularity.com
  • 24
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent..
Relevance: 45.93162
  • www.acepodia.com
  • 1
  • 1
  • 11
Acepodia was spun-off from Professor Carolyn Bertozzi 's lab who won the 2022 Nobel Prize for Chemistry and founded in 2017 by Dr. Patrick Y. Yang, former EVP of Juno Therapeutics, Roche and Genentech, and by Dr. Sonny Hsiao, UC Berkeley cell..
Relevance: 43.812096
  • www.smart-immune.com
  • 7
  • 20
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered cell therapy platform to fully and rapidly re-arm the immune system, enabling next-generation allogeneic T-cell therapies for all. The company was founded..
Relevance: 42.054237
  • pharmtechfocus.com
  • 3
  • 18
Quince Therapeutics, a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced... BioSenic, the clinical stage company specializing in serious autoimmune/inflammatory diseases and..
Relevance: 41.905304
  • pdcbio.com
  • 3
  • 1
  • 2
PDC Therapeutics is a clinical-stage biotechnology start-up developing smart nanomedicines for targeted therapies via a Polymer Drug Conjugate technology yielding to an optimal therapeutic index... PDC Therapeutics, a clinical-stage biotechnology..
Relevance: 41.307735
  • alphageneron.com
  • 1
  • 1
  • 7
Alphageneron Pharmaceuticals, Inc., is a privately-held clinical stage biotechnology company, developing targeted natural killer (NK) cell therapies which are supported by Companion Diagnostics. Alphageneron's team is comprised of industry veterans..
Relevance: 40.972157
  • www.gracellbio.com
  • 2
  • 1
Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapy. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is..
Relevance: 40.665127
  • brainstorm-cell.com
  • 1
  • 3
  • 19
BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the treatment of highly debilitating neurodegenerative diseases.....
Relevance: 39.954906
  • xnktherapeutics.com
  • 2
  • 19
XNK Therapeutics is a clinical-stage biotechnology company developing unique and individualized natural killer (NK) cell-based cancer therapies. The R&D pipeline targets areas of high unmet medical need within both hematological malignancies and..
Relevance: 39.730595
  • www.kuurtx.com
  • 2
  • 2
  • 19
Athenex is a clinical stage biotechnology company focused on the development of autologous and allogeneic NKT cell therapies to treat cancers. Our goal is to become a global leader in bringing innovative cancer treatments to the market and improving..
Relevance: 39.669136
  • coyatherapeutics.com
  • 4
  • 1
  • 19
We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells. We are currently developing our multi-modality Treg therapies for neurodegenerative, autoimmune, and..
Relevance: 39.58843
  • www.biosion.com
  • 1
  • 1
We are a clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases...
Relevance: 38.5719
  • tcbiopharm.com
  • 4
  • 1
  • 7
TC BioPharm (TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious..
Relevance: 38.482723
  • glycomimetics.com
  • 4
  • 2
  • 20
GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases. Our leading researchers leverage their deep understanding of the role that carbohydrates play..
Relevance: 38.454315
  • www.emmecell.com
  • 1
  • 9
Emmetrope Ophthalmics LLC, (aka "Emmecell") is a privately held, clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for the treatment of eye diseases via its exclusive Magnetic Cell Delivery (MCD)..
Relevance: 37.825077
  • sentrimed.com
  • 1
  • 1
  • 11
Sentrimed is a clinical stage biotechnology company developing novel targeted therapies that harness critical cell-to-cell communication processes essential to reviving the body's ability to recognize, contain and eliminate abnormal cells found in..
Relevance: 37.66888
  • www.abeonatherapeutics.com
  • 2
  • 1
  • 19
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona's lead clinical program is EB-101, its investigational autologous, gene-corrected cell therapy for recessive..
Relevance: 37.464855
  • cellenkosinc.com
  • 1
  • 1
  • 7
Cellenkos was founded in 2016 with the licensing of a proprietary umbilical cord blood T-Regulatory (Tregs) cell therapy platform from MD Anderson Cancer Center and funded by Golden Meditech Holdings Ltd, a Hong Kong-based integrated healthcare..
Relevance: 37.07591
  • innovakine.com
  • 2
Innovakine was founded in 2019 based on technology co-invented by Brad Nelson PhD of BC Cancer/Provincial Health Services Authority, Martin Boulanger PhD of the University of Victoria, and Zymeworks Inc., a clinical-stage biotechnology company...
Relevance: 36.884075
  • www.neuronatherapeutics.com
  • 1
  • 1
  • 21
Neurona is a clinical-stage biotherapeutics company developing regenerative cell therapies that permanently integrate into neural circuits, replace affected cells, and rebalance dysregulated electrical activity to repair the nervous system. Neural..
Relevance: 36.80327
  • novabiotics.co.uk
  • 1
  • 3
NovaBiotics Ltd is a leading clinical-stage biotechnology company focused on leveraging its novel immunology platforms to design and develop first-in-class therapies to address difficult-to-treat, medically unmet diseases... NovaBiotics' NM002..
Relevance: 36.697742
  • kyvernatx.com
  • 7
  • 1
  • 19
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases... Kyverna is pioneering CAR T-cell therapies for autoimmune disease patients by harnessing..
Relevance: 36.58956
  • www.cariboubio.com
  • 8
  • 1
  • 23
Caribou Biosciences is a pioneer in genome editing and cell therapy development, and we are seeking talented and passionate individuals to join our team... Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited..
Relevance: 36.129417
  • cytoart.com
  • 2
  • 1
Cytoart is a biotechnology company aimed at improving the development, quality control and clinical monitoring of CAR T-cell therapies. By offering our comprehensive anti-idiotypic platform, we are a leading provider of companion diagnostics for CAR..
Relevance: 35.64739
  • cell-source.com
  • 1
  • 3
  • 7
Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. Our patented Veto Cell technology is the centerpiece of treatment protocols that represent major breakthroughs in immune..
Relevance: 35.539
  • restem.com
  • 1
  • 1
  • 8
RESTEM is a leading clinical-stage biopharmaceutical company focused on the discovery and development of patient-specific, as well as off-the-shelf and ready-to-use, next-generation cell therapies that are designed to activate and enhance a patient's..
Relevance: 35.36748
  • stromabio.se
  • 1
StromaBio AB is a clinical stage biopharma company developing Mesenchymal Stromal Cell (MSC) based cell therapies. Founded on more than two decades of world leading research, our aim is to bring new advanced therapies to patients with Acute..
Relevance: 35.165913
  • imux.com
  • 5
  • 8
  • 19
Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases... Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective..
Relevance: 35.0846